InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: realist1 post# 204327

Thursday, 01/29/2015 2:49:12 PM

Thursday, January 29, 2015 2:49:12 PM

Post# of 346002

RE " PS Targeting = the biggest paradigm shift of all"

Been hearing that for OVER 10 years.
Shorts got rich.
Long got poor.
FACT.



The facts are shorts are called "traders" and many investors keep a portion of their holdings on the long side and trade with a portion of some.

The facts are "paradigm shifts" don't just happen overnight:

there is resistance = trying to buy out the company and/or BOD's

there is more resistance = Fargo (due to above failing)

there is even more resistance = Class Action lawsuits (due to above failing)

there is even much more resistance in other places and all will be washed out.

Want proof? Well Peregrine will save the proof for trial if needed but the shorts are all covering, which means they are at the end of their game. Now why in the world are all the shorts covering if things are as bad as you claim they are ? those there are some of them facts


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News